These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23985206)

  • 1. [Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing injection].
    Gao YL; Chai YF; Yao YM
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):162-5. PubMed ID: 23985206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Xuebijing injection on T helper 17 and CD4+ CD25+ regulatory T cells in patients with sepsis].
    Shao M; Liu B; Wang JQ; Tao XG; Zhou SS; Jin K; Zhang CP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jul; 23(7):430-4. PubMed ID: 21787474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of apoptosis of CD4+ CD25+ regulatory T cells on proliferation as well as secretion of effector T cells and interventional activity of Xuebijing injection in septic rats].
    Ai YH; Yao YM; Dai XG
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(1):58-61. PubMed ID: 19484954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of apoptosis of CD4+ CD25+ regulatory T lymphocytes on polarization of helper T lymphocytes and potential interventional influence of Xuebijing injection in septic rats].
    Dai XG; Yao YM; Ai YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):135-8. PubMed ID: 19278580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of treatment with Xuebijing injection on serum inflammatory mediators and Th1/2 of spleen in rats with sepsis].
    Zhang SW; Sun CD; Wen Y; Yin CH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):673-6. PubMed ID: 17092419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Host immunosuppression in pathogenesis of sepsis and its clinical implication].
    Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):138-41. PubMed ID: 17376264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A prospective multicenter clinical study of Xuebijing injection in the treatment of sepsis and multiple organ dysfunction syndrome].
    Gao J; Kong L; Liu S; Feng Z; Shen H; Liu Q;
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):465-70. PubMed ID: 26049185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status and prospect of integrative immune-therapy on pyaemia].
    Xiong XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):802-5. PubMed ID: 21038645
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the pathophysiology of the septic host upon admission?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effects of Xuebijing injection on kidney in rats with sepsis].
    Zhu XQ; Wang L; Liu QQ; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):680-3. PubMed ID: 17092422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation.
    Cheng C; Ren C; Li MZ; Liu YH; Yao RQ; Yu Y; Yu X; Wang JL; Wang LX; Leng YC; Zhang H; Du FF; Dong N; Wang FQ; Wu Y; Xu F; Zhu XM; Zhang GP; Dong K; Liu S; Yao XQ; Li C; Yao YM
    Acta Pharmacol Sin; 2024 May; 45(5):1077-1092. PubMed ID: 38267547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of traditional Chinese medicine in prevention and treatment of sepsis].
    Zhao GZ; Guo YH; Li B; Hu J; Chen TF; Di HR; Shao F; Liu QQ
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1423-1429. PubMed ID: 29071843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Xuebijing injection on levels of tissue factor-bearing microparticles in peripheral blood in septic rats].
    Yin DM; Sun Q; Li YP; Dong N; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):564-5. PubMed ID: 19751571
    [No Abstract]   [Full Text] [Related]  

  • 16. [The enhancing effect of "Xuebijing injection" on lipopolysaccharide-induced apoptosis of regulatory T cells and mediation of polarization of helper T cells].
    Dai XG; Yao YM; Ai YH; Yu Y
    Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):106-10. PubMed ID: 19799034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular changes in association with defense mechanisms in intra-abdominal sepsis.
    Pavlidis TE
    Minerva Chir; 2003 Dec; 58(6):777-81. PubMed ID: 14663404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics.
    Cheng C; Yu X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.
    Tidswell M; LaRosa SP
    Expert Rev Anti Infect Ther; 2011 May; 9(5):507-20. PubMed ID: 21609262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Xuebijing injection on protein C and tumor necrosis factor-alpha mRNA in rats with sepsis].
    Li YP; Qiao YJ; Wu ZX; Qian FF; Yao YM; Yu Y; Wu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Aug; 19(8):488-91. PubMed ID: 17708848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.